Loratadine (Loratidine; SCH 29851)

Alias: SCH29851; Loratadine; Claritin; Loratidine; Clarityn; Alavert; Loratadine; Sch 29851; Sch-29851; Sch29851
Cat No.:V1208 Purity: ≥98%
Loratadine (formerly SCH29851; SCH-29851; Claritin; Loratidine; Clarityn; Alavert) is a potent and 2nd-generation histamine H1 receptor antagonist which has been approved for the treatment ofallergies such as allergic rhinitis and urticaria.
Loratadine (Loratidine; SCH 29851) Chemical Structure CAS No.: 79794-75-5
Product category: Histamine Receptor
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
250mg
500mg
1g
2g
Other Sizes

Other Forms of Loratadine (Loratidine; SCH 29851):

  • Loratadine-d4 (Loratidine-d4; SCH 29851-d4)
  • Loratadine-d5 (Loratidine-d5; SCH 29851-d5)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Loratadine (formerly SCH29851; SCH-29851; Claritin; Loratidine; Clarityn; Alavert) is a potent and 2nd-generation histamine H1 receptor antagonist which has been approved for the treatment of allergies such as allergic rhinitis and urticaria. It also functions as a selective inhibitor of B(0)AT2 with IC50 of 4 μM. Loratadine doesn't have any effects that depress the central nervous system, like sleepiness. It has been demonstrated to suppress histamine and leukotriene C4 release from rodent mast cells as well as to suppress allergic bronchospasm in guinea pigs. Loratadine is an inverse peripheral histamine H1-receptor agonist that is selective.

Biological Activity I Assay Protocols (From Reference)
Targets
H1 receptor; B(0)AT2 ( IC50 = 4 μM )
ln Vitro

In vitro activity: Loratadine has been found to be a less active or inactive inhibitor of various other SLC6 family members, but it is a selective inhibitor of B(0)AT2 with an IC50 of 4 μM.[1] Loratadine suppresses the release of histamine and LTC4 in human Fc epsilon RI+ cells in a concentration-dependent manner when preincubated prior to Der p 1 antigen or anti-Fc epsilon RI challenge. Loratadine (0.1 mM) also prevents the release of PGD2, LTC4, and histamine (10–40%) from purified HLMC (16–68%) that have been activated by anti-Fc epsilon RI. In purified HSMC (24–72%) immunologically challenged with anti-Fc epsilon RI, loratadine causes concentration-dependent inhibition (10–40%) of histamine, tryptase, LTC4, and PGD2 release.[2] In human umbilical vein endothelial cells (HUVEC), loratadine significantly reduces the secretion of IL-6 and IL-8 that is triggered by histamine, with a more potent efficiency of the active metabolite.[3] Loratadine inhibits human hKv1.5 channels in Ltk-cells transfected with the hKv1.5 channel gene in a concentration-, voltage-, time-, and use-dependent manner, but only at concentrations significantly higher than therapeutic plasma levels.[4] Loratadine prevents the upregulation of ICAM-1 caused by rhinoviruses in respiratory epithelial cells, whether they are primary bronchial or transformed (A549). Additionally, loratadine completely blocks the activation of the ICAM-1 promoter induced by rhinovirus infection and inhibits the dose-dependent induction of ICAM-1 mRNA.[5]

ln Vivo

Animal Protocol


References

[1]. J Med Chem . 2014 Nov 26;57(22):9473-9.

[2]. Clin Exp Allergy . 1997 May;27(5):559-67.

[3]. Clin Exp Allergy . 1997 Oct;27(10):1167-74.

[4]. Cardiovasc Res . 1997 Aug;35(2):341-50.

[5]. J Allergy Clin Immunol . 2001 Aug;108(2):221-8.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C22H23CLN2O2
Molecular Weight
382.88
Exact Mass
382.14
Elemental Analysis
C, 69.01; H, 6.05; Cl, 9.26; N, 7.32; O, 8.36
CAS #
79794-75-5
Related CAS #
Loratadine-d4; 381727-27-1; Loratadine-d5; 1398065-63-8
Appearance
Solid powder
SMILES
CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
InChi Key
JCCNYMKQOSZNPW-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3
Chemical Name
ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate
Synonyms
SCH29851; Loratadine; Claritin; Loratidine; Clarityn; Alavert; Loratadine; Sch 29851; Sch-29851; Sch29851
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: 17~50 mg/mL (44.4~130.6 mM)
Water: <1 mg/mL
Ethanol: ~77 mg/mL (~201.1 mM)
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.53 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (6.53 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

View More

Solubility in Formulation 3: ≥ 2.5 mg/mL (6.53 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.


Solubility in Formulation 4: 5%DMSO + Corn oil: 4.0mg/ml (10.45mM)

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6118 mL 13.0589 mL 26.1178 mL
5 mM 0.5224 mL 2.6118 mL 5.2236 mL
10 mM 0.2612 mL 1.3059 mL 2.6118 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05421416 Not yet recruiting Drug: Loratadine
Drug: Placebo
Stem Cell Transplant
Complications
AHS Cancer Control Alberta November 1, 2023 Phase 2
NCT05243706 Not yet recruiting Drug: Loratadine
Drug: Diosmin/ Hesperidin
Vinca Alkaloid Adverse
Reaction
Ain Shams University March 1, 2022 Phase 3
NCT04211259 Recruiting Drug: Loratadine
Other: Placebo
Plasma Cell Myeloma Rutgers, The State University
of New Jersey
April 18, 2022 Early Phase 1
NCT06217367 Recruiting Drug: 10 mg Loratadine
Drug: 5 mg Desloratadine
Heat Illness
Allergic Rhinitis
Heat Injury
Lakehead University December 5, 2023 Phase 4
NCT02513290 Completed Drug: Bilastine
Drug: Loratadine
Allergic Rhinitis Universidade do Sul de
Santa Catarina
August 2013 Phase 4
Biological Data
  • Effects of loratadine on hKv1.5 channels expressed in a mouse L-cell. Cardiovasc Res . 1997 Aug;35(2):341-50.
  • Concentration dependence of loratadine-induced block of hKv1.5. Cardiovasc Res . 1997 Aug;35(2):341-50.
  • Effect of 1 μM loratadine on the steady-state current–voltage (I–V) relationships (500 ms isochronal). Cardiovasc Res . 1997 Aug;35(2):341-50.
Contact Us Back to top